Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Clin Cancer Res. 2020 Jan 15;26(8):1877–1885. doi: 10.1158/1078-0432.CCR-19-3467

Table 1.

Baseline Patient and Disease Characteristics

Characteristic N=138
Median age, years (range) 61 (21-87)
Sex (M) 84 (61%)
Race
   White 122 (88%)
   Asian 6 (4.3%)
   Black 2 (1.4%)
   Unknown 8 (5.8%)
Primary tumor location
   Colorectal 69 (50%)
   Pancreas 26 (19%)
   Biliary 18 (13%)
   Esophagogastric 17 (12%)
   Other 8 (5.8%)
Therapy types
   Cytotoxic therapy only 97 (70%)
   Targeted therapy only 23 (17%)
   Targeted + cytotoxic therapy 18 (13%)
Metastatic at Diagnosis 83 (60%)
Median time from metastatic diagnosis to treatment start, months (range) 2.1 (0-205)
Lines of prior metastatic therapy, median (range) 0 (0-6)
   1st line therapy 78 (57%)
   2nd line therapy 31 (22%)
   3rd line therapy or later 29 (21%)